Answers are grounded in this paper and cite their sources.
Identifies specific HLA-DRB1 alleles associated with anti-Caspr1 and anti-CNTN1 autoantibodies in autoimmune nodopathy, suggesting clinical significance.
BACKGROUND AND OBJECTIVES: This study describes the human leukocyte antigen (HLA) Class II allele frequencies in patients with anti-CNTN1+ and anti-Caspr1+ autoimmune nodopathy (AN). METHODS: database. In the anti-Caspr1+ group, we included 3 patients presenting with antibodies against both CNTN1 and Caspr1 proteins in the acute phase, in which the anti-CNTN1 antibodies disappeared in the chronic phase. DISCUSSION: HLA-DRB1*11 alleles are associated with the detection of anti-CNTN1 antibodies in AN patients, and HLA-DRB1*03:01 alleles associate with anti-Caspr1 antibodies. In addition, our study suggests that antiparanodal antibodies targeting both Caspr1 and CNTN1 are present in a small number of patients with AN. These data reinforce the idea that these patients represent specific subsets with clinical features and risk factors that differ from seronegative CIDP patients and from other AN patients. However, further studies should address the functional relevance of these associations and their pathophysiologic implications.
No takes yet. Share an insight, caveat, or question.
Lleixà et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: